EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Applying Endoscopic Submucosal Dissection for Treating Early Gastric Cancer

José Galindo, Jorge Rodríguez, Enrique Norero, Gloria Aguayo, Martha Pruyas, Eva Nilsen, Cristián Martínez, Sergio Báez, Alfonso Díaz, Alfonso Calvo

Cancer Plus · 2020

DOI: 10.18063/cp.v2i2.344 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Endoscopic submucosal dissection (ESD) is a standard method for the treatment of early gastric cancer and low risk of lymph node metastasis. Its advantage is to obtain a higher negative edge rate than mucosal resection and less trauma than surgery. Objectives: The short-term prognosis, pathological anatomy and long-term survival of ESD patients in our center were analyzed. Methods: Descriptive research. The clinical records of patients with early gastric injury treated with ESD from January 2008 to June 2012 were reviewed. Results: There were 15 patients included, 8 males and 7 females. The median age was 70 years (45–88). Tumor location: 2 cases in the upper third, 5 cases in the middle third and 8 cases in the lower third. The median tumor size was 13.5 mm (6–21). Most injuries are IIc. Among the postoperative complications, 1 case of gastrointestinal bleeding was treated by endoscopy and 3 cases of gastric perforation (gastric anastomosis) were treated by surgery. The average hospitalization was 3 days (1–23). There was no death record after operation. 86.7% of the cases had a negative edge. One case was positive at the deep edge after subtotal gastrectomy, and the other case was positive at the lateral edge. A new ESD treatment was used. The median follow-up was 16 months (7–61), and there was no pathological death of tumor. One case of tumor recurrence (51 months) was treated surgically. Conclusion: ESD is an alternative to the treatment of early gastric injury, allowing a high proportion of negative edges.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →